Mdma molecule:

Image from PubChem

Mdma Clinical Trials


Sub(acute) Neuropsychopharmacological Profiling of 2C-B Versus Psilocybin


To see complete record on www.trialregister.nl, please visit this link

Id: NL8813

Organisation Name: Maastricht University

Overal Status: Planned

Start Date: 2020-10-12

Lead Sponsor: Maastricht University

Brief Summary: 2C-B is a novel psychoactive substance (NPS) which is widely used among recreational drug users, serving as a template pro-drug for new drugs of abuse and sharing phenomenological similarities with well characterised compounds such as psilocybin and MDMA.
The study intends to provide a comprehensive neuropsychopharmacological evaluation of 2C-B's acute and persisting effects versus psilocybin. The overarching goal is to develop an imaging-metabolomics machine learning algorithm, which can predict the risk-profile of NPS
using point of care blood samples.

Country: Netherlands



Total execution time in seconds: 0.15758299827576